{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-004834","form_type":"8-K","ticker":"CDNA","cik":"0001217234","company_name":"CareDx, Inc.","filed_at":"2024-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.599066+00:00","generated_at":"2026-06-07T01:18:54.490181+00:00","sec_items":["2.02","9.01","7.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CareDx prelim FY2023 revenue $279-280M, above high end of guidance; Q4 patient volumes up 4% QoQ","bullets":["Full-year revenue expected $279-280M, exceeding $277M high-end guidance; FY2022 was $321.8M.","Q4 testing-services revenue $46-47M vs $47.8M in Q3; patient results ~39,900, up 4% sequentially.","Patient & Digital Solutions FY rev ~$37M (+29% YoY); Products ~$33.5M (+14% YoY).","Repurchased 2.8M shares for $26M; cash & equivalents $235M with no debt.","Fifth consecutive quarter of testing-services collections above 100% of revenue."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-004834","json":"https://secwatch.observer/filing/0001193125-24-004834.json","markdown":"https://secwatch.observer/filing/0001193125-24-004834.md","text":"https://secwatch.observer/filing/0001193125-24-004834.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1217234/000119312524004834/0001193125-24-004834-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1217234/000119312524004834/d93749d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:18:54.490181+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"589764ce1c55792874550bb3ab95609294b6e6ea","claim":"CareDx, Inc. reported the fourth quarter ended December 31, 2023 results: revenue between $65 million and $66 million.","evidence_excerpt":"Preliminary revenue for the three months ended December 31, 2023, is expected to be between $65 million and $66 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1217234/000119312524004834/0001193125-24-004834-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"between $65 million and $66 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"7b812c5ceeb5797de50793859ad2476a0dc090f9","claim":"CareDx, Inc. reported the full year ended December 31, 2023 results: revenue between $279 million and $280 million.","evidence_excerpt":"Preliminary revenue for the full year ended December 31, 2023, is expected to be between $279 million and $280 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1217234/000119312524004834/0001193125-24-004834-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2023"},{"label":"Revenue","value":"between $279 million and $280 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}